MARC details
000 -LEADER |
fixed length control field |
03481cam a2200589 i 4500 |
001 - CONTROL NUMBER |
control field |
ocn857062556 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20221128212357.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
fixed length control field |
m d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr ||||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
130605s2013 nyu ob 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2020687104 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
ISBN |
9781628083392 |
Qualifying information |
(ebook) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
ISBN |
1628083395 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
9781628083095 |
Qualifying information |
(hardback) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
622963 |
-- |
(N$T) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)857062556 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
HEA |
Subject category code subdivision |
039000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
014000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
022000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
112000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
045000 |
Source |
bisacsh |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
MAIN |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal author |
A�hmad, Suhail. |
245 10 - TITLE STATEMENT |
Title |
Tuberculosis and multidrug-resistant tuberculosis : |
Subtitle |
epidemiology, diagnosis, resistance mechanisms, treatment strategies and novel drugs |
Statement of responsibility, etc |
|
Medium |
[E-Book] |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
[Hauppauge] New York : |
Name of producer, publisher, distributor, manufacturer |
Nova Biomedical, |
Date of production, publication, distribution, manufacture, or copyright notice |
[2013] |
300 ## - PHYSICAL DESCRIPTION |
Physical description |
1 online resource. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
490 1# - SERIES TITLE |
Series statement |
Allergies and infectious diseases |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references (pages 79-128) and index. |
505 0# - CONTENTS |
Contents |
TUBERCULOSIS AND MULTIDRUG-RESISTANT TUBERCULOSIS ; TUBERCULOSIS AND MULTIDRUG-RESISTANT TUBERCULOSIS ; Library of Congress Cataloging-in-Publication Data ; Contents; Preface ; Chapter I Natural History of Tuberculosis ; Chapter II Global Epidemiology of TB, Drug-Resistant TB, MDR-TB and XDR-TB ; Chapter III Chemotherapy for TB and Evolution of Drug-Resistant TB ; Chapter IV Anti-TB Drugs: ChMechanism of Action and Molecular Basis of Resistance ; Chapter V Diagnosis of Active TB Disease ; Chapter VI Diagnosis of Drug-Resistant TB, MDR-TB and XDR-TB. |
505 8# - CONTENTS |
Contents |
6A. Conventional Diagnosis of Drug-Resistant TB, MDR-TB and XDR-TB 6B. Molecular Diagnosis of Drug-Resistant TB, MDR-TB and XDR-TB ; Chapter VII Treatment of Drug-Resistant TB, MDR-TB and XDR-TB ; 7A. Treatment of Drug-Resistant TB, MDR-TB and XDR-TB in HIV-Seronegative Adults ; 7B. Treatment of Drug-Resistant TB in Children ; 7C. Treatment of Drug-Resistant TB in HIV-Coinfected Patients ; Chapter VIII New Drugs for the Treatment of TB and Drug-Resistant TB ; 8A. Clinical Re-evaluation of Existing Drugs ; 8B. New Anti-TB Drugs Under Development ; 8B.1. New Drugs under Clinical Evaluation. |
505 8# - CONTENTS |
Contents |
8B.2. New Drugs in Preclinical Development 8B.3. Promising Lead Compounds as Anti-TB Drugs; Chapter IX Concluding Remarks ; References; Index. |
590 ## - LOCAL NOTE (RLIN) |
Local note |
Master record variable field(s) change: 050, 082, 650 |
650 #0 - SUBJECT HEADINGS |
Subject term |
Tuberculosis. |
650 #0 - SUBJECT HEADINGS |
Subject term |
Multidrug-resistant tuberculosis. |
650 #0 - SUBJECT HEADINGS |
Subject term |
Multidrug-resistant tuberculosis |
General subdivision |
Chemotherapy. |
650 #0 - SUBJECT HEADINGS |
Subject term |
Antitubercular agents. |
9 (RLIN) |
5248 |
700 1# - ADDED PERSONAL NAME |
Added personal author |
Mokaddas, Eiman. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Allergies and infectious diseases. |
856 40 - ONLINE RESOURCE |
Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=622963">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=622963</a> |
Link text |
Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Suppress in OPAC |
Do not Suppress in OPAC |
588 ## - SOURCE OF DESCRIPTION NOTE |
Source of description note |
Description based on print version record. |
938 ## - |
-- |
YBP Library Services |
-- |
YANK |
-- |
11055473 |
938 ## - |
-- |
EBSCOhost |
-- |
EBSC |
-- |
622963 |
938 ## - |
-- |
ebrary |
-- |
EBRY |
-- |
ebr10740851 |
938 ## - |
-- |
ProQuest Ebook Central |
-- |
EBLB |
-- |
EBL3022921 |
994 ## - |
-- |
92 |
-- |
N$T |